Anda di halaman 1dari 2

Case 33

Benign Loculated Pleural


Effusion
Kavitha Yaddanapudi

History Discussion

A 52-year-old male with chronic lymphoid leu- Pleural disease ranges from simple pleural effu-
kemia presents for restaging with PET/MRI sions to complex effusions and pleural masses. A
(Fig. 33.1). pleural effusion is an accumulation of fluid in the
pleural space. Pleural effusions are broadly clas-
sified as transudative or exudative. Pleural fluid
Diagnosis may become loculated within the fissures or
between the visceral and parietal pleural layers.
Benign loculated pleural effusion This most commonly occurs with exudative fluid,
blood, and pus. When loculated pleural fluid
becomes infected, it is termed an empyema,
Findings which can be potentially life-threatening, requir-
ing prompt diagnosis and treatment. Often times,
• Loculated fluid is heterogenously T1 and T2 the lung parenchyma around the pleural fluid col-
hyperintense indicating exudative fluid (wide lapses, causing atelectasis that can lead to short-
arrows). T2-weighted low-signal septations ness of breath.
are identified (arrowheads). On cross-sectional axial images, pleural effu-
• Areas of low T1 and T2-weighted signal glob- sions appear as semicircular dependent fluid col-
ules represent areas of old hemorrhage (thin lections. MR imaging demonstrates simple
arrow). transudative pleural effusions with homogenous
• Moderate-sized loculated pleural effusion in the hyperintense signal on T2-weighted imaging. On
right lung base with no significant FDG uptake T1-weighted images, simple or transudative effu-
on PET imaging signifying a benign collection. sions are hypointense relative to the muscle,
• Pleural thickening and atelectasis surrounding whereas complex and exudative effusions are
the loculated fluid collection with mild FDG hyperintense on T1-signifying proteinaceous
activity indicate chronic inflammation. material, chyle, or hemorrhagic products. MRI is

© Springer International Publishing AG 2018 77


R. Gupta et al., PET/MR Imaging, https://doi.org/10.1007/978-3-319-65106-4_33
78 K. Yaddanapudi

Fig. 33.1  T1 radial VIBE axial with fat suppression (a), T2 HASTE axial (b), T2 TSE coronal (c), PET/MR T1 radial
VIBE with fat suppression axial fusion (d), and PET axial (e)

also helpful in identifying associated pleural in effusions. FDG PET/MR imaging is useful in
thickening and nodularity including pleural the assessment of complex effusions to further
metastases. Additionally, MRI is useful in identi- characterize and identify potential FDG-avid
fying septa between the loculations and debris biopsy sites. FDG uptake can also be assessed
within the effusion. Thus, MRI offers better prior to radiotherapy in malignant effusions to
characterization of pleural effusions than CT. guide radiation treatment plan. The lack of sig-
Recently diffusion-weighted imaging has been nificant FDG uptake and pleural thickening
shown to be useful in differentiating transudative favors benign effusions.
from exudative effusions.
FDG PET shows increased uptake in inflam-
matory, parapneumonic effusions and malignant Suggested Reading
effusions. Malignant effusions may be associated
Inan N, Arslan A, Akansel G, Arslan Z, Elemen L,
with more nodular or ringlike pleural FDG uptake Demirci A. Diffusion-weighted MRI in the charac-
especially in pleural metastases or malignant terization of pleural effusions. Diagn Interv Radiol.
pleural mesothelioma. In patients with a known 2009;15(1):13–8.
malignancy, FDG PET has been reported to have Porcel JM, Hernández P, Martínez-Alonso M, Bielsa
S, Salud A. Accuracy of fluorodeoxyglucose-PET
moderate accuracy in differentiating benign from imaging for differentiating benign from malig-
malignant effusions. Visual and semiquantitative nant pleural effusions: a meta-analysis. Chest.
analysis can both be used to assess FDG uptake 2015;147(2):502–12.

Anda mungkin juga menyukai